The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Osimertinib plus repotrectinib phase I trial in TKI-resistant non-small cell lung cancer (NSCLC) with EGFR mutations.
 
Andrés Aguilar Hernandez
No Relationships to Disclose
 
Manuel Cobo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Kyowa Kirin International; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Kyowa Kirin International; Lilly; MSD; Novartis; Novocure; Pierre Fabre; Roche; Sanofi; Takeda
 
Alexandra Cantero
No Relationships to Disclose
 
Antonio Calles
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi/Regeneron; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; IGEN BIOTECH; Johnson & Johnson/Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Sanofi/Regeneron; Summit Therapeutics; Takeda
Research Funding - MSD Oncology
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD Oncology; Pfizer
 
Rosa Álvarez Álvarez
No Relationships to Disclose
 
Aitor Azkarate
No Relationships to Disclose
 
Raquel Marse Fabregat
No Relationships to Disclose
 
Emiliano Agüero
No Relationships to Disclose
 
Alejandro Martinez-Bueno
No Relationships to Disclose
 
Maria Gonzalez-Cao
No Relationships to Disclose
 
Ivana Gabriella Sullivan
No Relationships to Disclose
 
Miguel Angel Molina Vila
No Relationships to Disclose
 
Rafael Rosell
Consulting or Advisory Role - Blueprint Medicines; Merck KGaA